Drug Repurposing for Rare Diseases 2022

09:00 – 18:00, 10th October 2022

America Square Conference Centre, London

#DrugRepo22 begins in

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

We are delighted to announce our ninth annual Drug Repurposing for Rare Diseases Conference and, for the first time since 2020, it’s returning live and in-person!

Our annual conference, Drug Repurposing for Rare Diseases, highlights the role that drug repurposing can play in lowering the cost and accelerating the development of rare disease treatments.

An event unique in its collaborative and multi-stakeholder focus, we bring patient groups, researchers and industry professionals together to showcase excellent examples of rare repurposing.

Drug Repurposing for Rare Diseases sparks cross-sector conversation, uniting the expertise of diverse groups to inspire meaningful, patient-centred drug repurposing research for rare diseases.

What can you expect at #DrugRepo22

Expert speakers highlighting major projects driving repurposing across the UK and Europe

Quickfire presentations proposed and delivered by registered delegates

Opportunities to make valuable connections with repurposing innovators, patient group pioneers and market access experts

Illustrations of excellence in academia, industry, healthcare and patient advocacy

Inspiring examples of determination, resilience and strength within the rare disease community

Complimentary food and refreshments throughout and a closing drinks reception

Don’t take our word for it. Hear from our previous delegates!

“The discussions were fascinating. A fantastic selection of presentations and a great variety of perspectives”

“One of the best conferences on rare diseases in Europe. It’s critical to get us all together in beating these terrible conditions”

“Beacon always hold great events for the rare disease sector. Industry rubbing shoulders with patient groups and actually having real conversations is invaluable”

“I was really excited to see all the work that is going on in this area. I made some really great connections and it seems this is an area which is ripe for further policy discussions.”

“Thank you for putting together an excellent conference. The talks were all very interesting and the Q/A sessions very engaging. It was a great opportunity to catch up with the community.”

What opportunities are available? 

Speaking opportunities

If you’re a researcher, healthcare professional, patient or patient group with experience of repurposing for rare diseases, get in touch with maryrose@rarebeacon.org to discuss how we can share your journey at our conference.

We also offer opportunities for companies to share their drug repurposing work as part of our sponsorship packages, get in touch with sophia@rarebeacon.org to find out more.

Interested in presenting a lightning talk? 

All delegates who register for our conference by 1st September will have the opportunity to submit a proposal for a 5-minute lightning talk.

A good lightning talk condenses a couple of ideas to their essence, inspiring the audience to go searching for more information. Lightning talks don’t need to focus on repurposing, if you’ve got a rare story to tell, we want to hear it!

Sign up now to submit your proposal.

Sponsorship and exhibition opportunities

Opportunities for companies

We have a range of partnership packages suitable for every budget, which include opportunities to speak, exhibit and advertise.

What’s more, by partnering with Drug Repurposing for Rare Diseases 2022, you will be providing an opportunity for all members of the rare disease community to meet – in person – and share ideas, making a life changing difference to the millions of patients and families living with rare diseases.

Get in touch with sophia@rarebeacon.org to discuss your options.

Opportunities for patient groups

We have a limited number of exhibition opportunities available for patient groups, and priority will be given to those with connections to drug repurposing. To express your interest, get in touch with maryrose@rarebeacon.org.